FDA has authorized the emergency use of certain filtering facepiece respirators (FFRs) for use in health care settings by health care personnel (HCP) in accordance with the Centers for Disease Control and Prevention (CDC) recommendations to prevent HCP exposure to pathogenic biological airborne particulates during FFR shortages resulting from the COVID-19 outbreak.
READ MORE




